We are live on ! Find out more
IBER.WS

Ibere Pharmaceuticals Warrants
IBER.WS

Delisted

IBER.WS was delisted on the 15th of February, 2023.

36 hedge funds and large institutions have $618K invested in Ibere Pharmaceuticals Warrants in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

9% more funds holding

Funds holding: 33 → 36 (+3)

20% less capital inflows, than outflows

Capital inflows: $87.2K | Capital outflows: $109K

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
36
Holders Change
+3
Holders Change %
+9.09%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
3
Closed
3
Calls
$2.22​M
Puts
–
Net Calls
+$2.22​M
Net Calls Change
-⁠$2​K

IBER.WS Hedge Fund Activity: Q2 2022 in Review

36 of the 5,961 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Warrants (IBER.WS) for Q2 2022, worth a combined $618K — down 37% from $987K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new IBER.WS positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Clear Street, opening a new position worth an estimated $31K. The largest seller was Citadel Advisors, cutting an estimated $52.5K.

  • 36 institutional investors held Ibere Pharmaceuticals Warrants (IBER.WS) as of Q2 2022, up from 33 in Q1 2022.
  • Funds reported $618K of Ibere Pharmaceuticals Warrants stock for Q2 2022, down 37% quarter-over-quarter.
  • 5 funds opened new Ibere Pharmaceuticals Warrants positions in Q2 2022 and 3 closed out, a net change of +2 holders.
  • The largest Ibere Pharmaceuticals Warrants buyer in Q2 2022 was Clear Street, an estimated $31K added.
  • The largest Ibere Pharmaceuticals Warrants seller in Q2 2022 was Citadel Advisors, an estimated $52.5K sold.

Based on aggregated 13F filings for Q2 2022.